All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Do people over 35 actually need peptides? A fact-check

Juan Zuniga

TikTok creator

1.5K viewsWatch on TikTok→

Quick answer

The video recommends tesamorelin, an unidentified peptide called 'redo,' PT-141 (bremelanotide), and a GHK-Cu blend for men over 35 seeking body recomposition, improved libido, and cosmetic benefits. Tesamorelin and PT-141 are FDA-approved drugs for narrow indications requiring prescriptions and medical monitoring, not general wellness supplements. The 'glow stack' blend lacks transparent ingredient disclosure, making independent safety or efficacy assessment impossible.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @juanczunigajr actually say?

The creator made four specific product claims targeting men over 35 dealing with body composition, libido, and hair loss. He recommended "tesamorella" (almost certainly tesamorelin) for visceral fat and lean muscle, a peptide he called "redo" (likely retatrutide or possibly retinalon, though the transcription is unclear) for insulin sensitivity and fat loss, PT-141 for libido and arousal, and a "glow stack" containing GHK-Cu for skin, hair, and gut health.

The pitch follows a familiar pattern: you're struggling, here's the fix, and you'll feel "like you're in your 20s again." No dosing context, no mention of medical supervision, no acknowledgment that most of these peptides are not FDA-approved for the uses he describes. That omission matters a lot, and we'll get into why.

Does the science back this up?

Partially, and only in specific clinical contexts, not as general supplements for any man over 35. The evidence ranges from reasonably solid (tesamorelin for visceral fat) to genuinely thin (the "glow stack" for hairline regrowth).

Tesamorelin has the strongest backing of anything mentioned. It is FDA-approved, specifically for HIV-associated lipodystrophy, where it has demonstrated significant reductions in visceral adipose tissue. Falutz et al. (2010, New England Journal of Medicine) showed statistically significant VAT reduction in a double-blind trial. But that approval is narrow. Using it off-label as a general body composition tool in healthy men is extrapolation, not established medicine.

PT-141 (bremelanotide) is actually FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Its mechanism through melanocortin receptors is real. Safarinejad (2008, Journal of Sexual Medicine) showed efficacy in men with erectile dysfunction, but side effects including nausea and blood pressure increases were notable. Calling it "forget that blue pill" oversimplifies a more complicated picture.

GHK-Cu has interesting in vitro data for collagen synthesis and wound healing, but clinical trial evidence for topical or systemic use in humans is sparse. The hair regrowth claim in particular lacks robust human RCT support.

What did they get wrong (or right)?

Credit where it is due: the core mechanisms described for tesamorelin and PT-141 are not invented. Growth hormone-releasing hormone analogs do affect visceral fat. PT-141 does work through brain arousal pathways, not just vascular mechanisms like PDE5 inhibitors. Those distinctions are real.

But several things are wrong or misleading. First, "tesamorella" has FDA approval for a specific disease population, not for general use in healthy aging men. Presenting it as something any man over 35 "should be taking" misrepresents the regulatory and clinical reality. Second, the peptide he calls "redo" is phonetically ambiguous in the transcript, and no well-documented peptide with that name exists for insulin sensitivity at the time of this writing, which is a red flag. Third, the claim that GHK-Cu helps with "your receding hairline" has essentially no clinical trial support in humans. A few small studies exist on topical formulations, but nothing that supports the confident claim made here.

Most importantly, none of these are over-the-counter supplements. Several exist as compounded preparations that are not FDA-approved drugs. The video presents them as straightforward self-administered interventions, which is not accurate or safe framing.

What should you actually know?

If you're a man over 35 experiencing the symptoms described here, those symptoms are real and worth addressing. But the pathway matters. Tesamorelin requires a prescription and monitoring. PT-141 is a prescription drug with documented side effects. Compounded peptides exist in a regulatory gray zone where quality control is not guaranteed.

The bigger issue is the stack framing. Combining multiple peptides without medical supervision introduces unknown interaction risks. No clinical trial has evaluated this specific combination for safety or efficacy. The "glow stack" in particular is a proprietary blend, which means you cannot independently verify what is in it or in what concentrations.

If any of these peptides interest you, the right move is a consultation with a physician who can evaluate your hormone panels, metabolic markers, and health history before recommending anything. A TikTok video is not a clinical workup.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Do people over 35 actually need peptides? A fact-check, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Do people over 35 actually need peptides? A fact-check should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim verdict

The useful answer behind this video

Claim being checked

The video recommends tesamorelin, an unidentified peptide called 'redo,' PT-141 (bremelanotide), and a GHK-Cu blend for men over 35 seeking body recomposition, improved libido, and cosmetic benefits.

FormBlends verdict

The video recommends tesamorelin, an unidentified peptide called 'redo,' PT-141 (bremelanotide), and a GHK-Cu blend for men over 35 seeking body recomposition, improved libido, and cosmetic benefits. Tesamorelin and PT-141 are FDA-approved drugs for narrow indications requiring prescriptions and medical monitoring, not general wellness supplements. The 'glow stack' blend lacks transparent ingredient disclosure, making independent safety or efficacy assessment impossible.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video recommends tesamorelin, an unidentified peptide called 'redo,' PT-141 (bremelanotide), and a GHK-Cu blend for men over 35 seeking body recomposition, improved libido, and cosmetic benefits. Tesamorelin and PT-141 are FDA-approved drugs for narrow indications requiring prescriptions and medical monitoring, not general wellness supplements. The 'glow stack' blend lacks transparent ingredient disclosure, making independent safety or efficacy assessment impossible.
  • Tesamorelin is FDA-approved only for HIV-associated lipodystrophy; Falutz et al. (2010, NEJM) showed VAT reduction in that population, not in healthy aging men seeking body recomposition.
  • PT-141 (bremelanotide) is a real FDA-approved drug sold as Vyleesi, but it is approved for premenopausal women with HSDD and carries documented side effects including nausea and blood pressure increases.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Tesamorelin is FDA-approved only for HIV-associated lipodystrophy; Falutz et al. (2010, NEJM) showed VAT reduction in that population, not in healthy aging men seeking body recomposition.
  • PT-141 (bremelanotide) is a real FDA-approved drug sold as Vyleesi, but it is approved for premenopausal women with HSDD and carries documented side effects including nausea and blood pressure increases.
  • The peptide referred to as 'redo' in the transcript cannot be verified as a recognized compound with clinical evidence for insulin sensitivity, which should be treated as a significant red flag.
  • GHK-Cu has interesting lab data for collagen synthesis but lacks human randomized controlled trial evidence for hair regrowth or the cosmetic claims made in this video.
  • Most peptides discussed here are prescription-required or exist as unregulated compounded preparations; none are appropriate for unsupervised self-administration based on a social media recommendation.
  • Combining multiple peptides without physician oversight introduces unknown interaction risks that no published study has evaluated in this specific context.
  • If you are experiencing low libido, body composition changes, or hair loss after 35, these are legitimate clinical concerns that warrant lab work and a physician consultation, not a peptide stack from a TikTok video.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Juan Zuniga · TikTok creator

1.5K views on this video

If you are over 35 you need to take these peptides

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Juan Zuniga, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.